medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2007, Number 5

<< Back Next >>

Rev Mex Oftalmol 2007; 81 (5)

Estudio clínico comparativo de la eficacia de dos concentraciones de ciclopentolato tópico oftálmico en población pediátrica

Baiza-Durán LM, González JR, Quintana HJD

Language: Spanish
References: 13
Page: 250-252
PDF size: 36.03 Kb.


ABSTRACT

Purpose: To compare the mydriatic efficacy of two different concentrations of cyclopentolate applied in healthy children.
Material and methods: Prospective, descriptive, double blind and longitudinal study. We included 30 eyes from 30 patients, between 1 and 12 years of age, in all a refraction study was performed. In each one in a randomized way one of the two formulations of topic cyclopentolate eye drops (0.5%-15 patients, 1%-15 patients) were applied into the lower cul-de-sac of right eye. Horizontal and vertical pupil diameters were measured at different time intervals.
Results: The 0.5% cyclopentolate eye drops treatment group showed the same vertical and horizontal pupil diameters as the 1% cyclopentolate eye drops treatment group. No statistical differences were observed between both groups.
Conclusions: The effectiveness to produce mydriasis in children was similar for both concentrations.


REFERENCES

  1. Hakim Kaila T, Huupponen R, Salminen L, Iisalo E. Systemic absorption of ophthalmic cyclopentolate. Am J Ophthal. 1989; 107:562-64.

  2. Mydriatics and cycloplegics. En: Ophthalmic Drug Facts 2004. Bartlett JD (Ed). Wolters Kluwer Healt Inc. St. Louis, 2004, pp 41-45.

  3. Zimmerman CF, Hogan RN, Le TD. Mydriatics and cycloplegic drugs. En: Zimmerman TJ, Kooner KS, Sharir M (eds). Textbook of Ocular Pharmacology. Lippincott-Raven Publishers, Philadelphia, 1997. pp 274-275.

  4. Fraunfelder FT, Meyer SM. Vasopressors. En: Fraunfelder FT, Meyer SM (eds). Drug-Induced Ocular Side Effects and Drug Interactions. Lea & Febiger, Philadelphia, 3a ed, 1989. pp 318-319.

  5. Diagnostic techniques for strabismus and amblyopia. En: Section 6 Pediatric Ophthalmology and Strabismus. American Academy of Ophthalmology (Ed). Lifelong Education for the Ophthalmologist, San Francisco, 1996-1997. pp 286-287.

  6. Khoo BK, Koh A, Cheong P, Ho NK. Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides. J Ped Ophthal Strab 1994; 37:15-20.

  7. Awan KJ. Emotional changes from topical ocular cyclopentolate. Ann Ophthal 1976; 695.

  8. Rosales T, Isenberg S, Leake R, Everett S. Systemic effect of mydriatics in low weight infants. J Ped Ophthalmol Strab 1981; 18:42-46.

  9. Patton TF, Robinson JR. Pediatric dosing considerations in ophthalmology. J Ped Ophthal1976; 13:171-178.

  10. Palmer EA. How safe are ocular drugs in pediatrics? Ophthalmology 1986; 93: 1038-40.

  11. Kaila T, Huupponen R, Salminen L. Systemic absorption of ophthalmic cyclopentolate. Am J Ophthalmol 1989; 107:562-564.

  12. Brenner RL. Pupillary dilatation with single eyedrop mydriatic combinations. Am J Ophthalmol 1980; 90:271.

  13. Apt L, Henrick A. Pupillary dilatation with single eyedrop mydriatic combinations. Am J Ophthalmol 1980; 89:553-559.




2020     |     www.medigraphic.com